Newsroom
In a 12-week feeding intervention trial, LIN’ team has found that both non-calorie-restricted low-carbohydrate (LC) diet and a traditional high-carbohydrate diet with 35% energy reduction comparably reduced bodyweight, but only LC diet showed additional benefits on blood lipid profile in overweight/obese Chinese women.
Based on the samples and data of this trial, LI and LIN's teams and ZENG's team further measured the changes of metagenomics and targeted-metabolomics by using the samples collected in baseline and 12-week after intervention. They discovered for the first time that different weight-loss diets caused different changes in structure and function of gut microbiota, as well as participant’s blood levels of fatty acids and acylcarnitines.
Stepwise regression analysis showed that the changes in a series of co-abundance gene clusters (CAG) of gut microbiota, as well as blood fatty acids and acylcarnitines, were found to be significantly associated with improved blood high-density lipoprotein cholesterol (HDL) and triglycerides. Besides, changes in CAGs made greater contributions to elevated HDL levels and reduced triglycerides levels than contributions made by changes in fatty acids and acylcarnitines.
This study provides novel evidence to uncover that different diet-induced changes of gut microbiota might exert greater impact than altered host metabolism on improved dyslipidemia, supporting the important role of the complex “diet-microbiota-host” interactions on cardiometabolic health.